Wuhan Binhui Biopharmaceutical Co., Ltd.
PrivateLast Round
Private Equity
Dec 1, 2023
Est. Valuation
$450M
Total Funding Raised
$159.8M
Company Overview
Wuhan Binhui Biopharmaceutical Co., Ltd. is a biotechnology company that specializes in the research, development, and production of oncolytic virus drugs and other macromolecular therapeutic products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wuhan Binhui Biopharmaceutical Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Wuhan Binhui Biopharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Dec 1, 2023 | ||||
| Series B Extension | Apr 19, 2022 | ||||
| Series B | Feb 25, 2021 | ||||
| Series A | Aug 4, 2018 |
Wuhan Binhui Biopharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hubei Provincial High-Tech Industry Investment Group | Series B Extension |
| CCIC Capital | Series B |
| Haoyue Capital | Series B |
| Qianhai Ark Asset Management | Series B |
| Share Capital | Series B |
| Ming Capital | Series B Extension |
| Vertex Ventures China | Series B |
Wuhan Binhui Biopharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Wuhan Binhui Biopharmaceutical Co., Ltd.'s valuation, stock price, and market status.